Graphite Bio Inc (GRPH) Stock: Do Analysts Think You Should Buy?

Wednesday, November 15, 2023 10:03 AM | InvestorsObserver Analysts

Mentioned in this article

Graphite Bio Inc (GRPH) Stock: Do Analysts Think You Should Buy?

InvestorsObserver is giving Graphite Bio Inc (GRPH) an Analyst Rating Rank of 4, meaning GRPH is ranked higher by analysts than 4% of stocks. The average price target for GRPH is $3.75 and analyst’s rate the stock as a Hold.

Wall Street analysts are rating GRPH a Hold today. Find out what this means to you and get the rest of the rankings on GRPH!

See Full GRPH Report

Why are Analyst Ratings Important?

Though analyst projections should not be your only resource when determining your position on a stock, it can be a very useful tool. Analysts follow sectors/industries in-depth and tend to know how local and global conditions tend to affect demand and prices. Many analysts even participate in conference calls where they can get information to better make sense of the numbers. InvestorsObserver averages the ratings provided by analysts and then ranks their score as a percent against the market. This allows you to compare stocks in a more comprehensive fashion than with the typical buy/sell/hold ranking.

What's Happening With Graphite Bio Inc Stock Today?

Graphite Bio Inc (GRPH) stock has fallen -11.16% while the S&P 500 is higher by 0.26% as of 10:01 AM on Wednesday, Nov 15. GRPH is lower by -$0.26 from the previous closing price of $2.33 on volume of 286,441 shares. Over the past year the S&P 500 is up 12.91% while GRPH is lower by -41.36%. GRPH lost -$2.29 per share the over the last 12 months. Click Here to get the full Stock Report for Graphite Bio Inc stock.